GENFIT, a biopharmaceutical company, has named Dr. Catherine Larue executive vice-president, biomarkers.

Before joining GENFIT, Larue spent eleven years within the Bio-Rad group, where she occupied various management positions, ranging from an R&D department to the direction of a business unit.

“We are delighted by the arrival of Catherine Larue at GENFIT. Her experience, particularly in development, and her dynamic nature will enable us to significantly intensify our biomarker activity, for which our principal research programs are advancing rapidly and for which we expect to have numerous commercial prospects,” said Jean-François Mouney, CEO & chairman of GENFIT's management board.